Straumann USA LLC is the U.S. subsidiary of the Straumann Group, a global leader in oral health based in Basel, Switzerland. The parent company, Straumann Holding AG, became publicly traded on the SIX Swiss Exchange in 1998, though its dental-focused operations began in 1990. Straumann USA LLC's North American headquarters and a manufacturing unit are located in Andover, Massachusetts.
The company focuses on the research, development, manufacture, and supply of products for replacement, restorative, orthodontic, and preventative dentistry. Its extensive offerings include dental implants, instruments, biomaterials, CAD/CAM prosthetics, digital equipment, software, and clear aligners. Straumann USA LLC specifically provides implant, restorative, and regenerative products for both conventional and digital workflows, and produces implant system components and instruments.
In patent litigation, Straumann USA LLC acts as an operating company that defends its interests. While the provided data lists one plaintiff case at the Patent Trial and Appeal Board (PTAB), this action is a defensive measure. Straumann USA LLC filed a Post-Grant Review (PGR) against Smart Denture Conversions LLC to challenge U.S. Patent No. 11,937,992. This PTAB proceeding directly relates to a patent infringement lawsuit initiated by Smart Denture Conversions, LLC against Straumann USA, LLC in the U.S. District Court for the District of Delaware (Case No. 1:24-cv-00507-JCB). The District Court case has been administratively closed pending the outcome of the PTAB review.